ruthenium has been researched along with Disease Models, Animal in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (14.29) | 29.6817 |
| 2010's | 15 (71.43) | 24.3611 |
| 2020's | 3 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Booysen, IN; Gamede, MW; Khathi, A; Mabuza, LP; Maikoo, S; Ngubane, PS | 1 |
| Chen, C; Yang, K | 1 |
| Chen, X; Ding, X; Martin, LL; Sun, D; Wang, J; Wang, W; Wang, Z; Yang, E; Yin, C | 1 |
| Bridle, KR; Crawford, DH; Jayachandran, A; Liang, X; Liu, X; Roberts, MS; Thomas, JA; Wang, H; Xu, ZP; Yuan, J; Zhang, R; Zhang, W | 1 |
| Alzahrani, EMS; Attina, A; Gibbins, J; Greco, F; Javed, M; Kabova, E; Osborn, HMI; Pothi, R; Ravishankar, D; Salamah, M; Shankland, K; Strohfeldt, K; Vaiyapuri, R; Vaiyapuri, S; Vallance, TM; Williams, HF | 1 |
| Al-Hallaf, R; Collins, JG; Eichenberger, RM; Giacomin, PR; Keene, FR; Loukas, A; Pearson, MS; Rajan, S; Sotillo, J; Sundaraneedi, M; Wangchuk, P; Yang, D | 1 |
| Becker, L; Collins, JG; Eichenberger, RM; Keene, FR; Loukas, A; Pearson, MS; Pickering, D; Rajan, S; Smout, MJ; Sundaraneedi, MK; Tedla, BA; Wangchuk, P | 1 |
| Antonawich, F; Cox, C; Garnett, M; Golightly, MG; Hamidi, SA; Harrington, A; Huang, PH; Levine, L; Li, J; Lin, D; McClain, S; Miller, E; Qamar, N; Razi, R; Rueb, T; Schmidt, M; Szema, AM; Zimmerman, T | 1 |
| Benadiba, M; Colquhoun, A; DE Oliveira Silva, D; Miyake, JA; Ribeiro, G | 1 |
| Batista, AC; Castro, PF; Costa, SH; da Silva, RS; de Andrade, DL; Reis, Cde F; Rocha, ML | 1 |
| Guo, QF; Liang, JB; Liu, SH; Liu, YM; Wang, Y; Wang, YX; Wu, Y; Xu, HH; Zhang, GQ; Zhu, JW | 1 |
| Barreto, BC; Basilico, N; Batista, AA; Colina-Vegas, L; D'Alessandro, S; DA Paixão, M; Macambira, SG; Macedo, TS; Machado, M; Moreira, DR; Navarro, M; Oliveira, PC; Prudêncio, M; Soares, MB | 1 |
| Cao, R; He, N; Huang, FY; Huang, J; Lu, Z; Tan, GH; Wang, G; Zhang, L; Zhang, Z | 1 |
| Ding, XL; Ge, HY; Jiang, H; Ning, LP; Wang, R; Wang, YH; Yue, SW; Zhang, Y | 1 |
| Alcaraz, MJ; Devesa, I; Ferrándiz, ML; Koenders, MI; Maicas, N; Motterlini, R; van den Berg, WB | 1 |
| Bremer, E; Chen, P; de Bruyn, M; Helfrich, W; Wei, Y; Zhang, W | 1 |
| Campelo, AP; Campelo, MW; Guimarães, SB; Lopes, LG; Santos, AA; Vasconcelos, PR | 1 |
| Figueiredo, LE; Franco, DW; Gomes, AJ; Tavares, A; Tfouni, E; Truzzi, DR | 1 |
| Cocchietto, M; Sava, G; Sorc, A; Zorzet, S | 1 |
| Fricker, SP | 1 |
| Bendhack, LM; da Silva, RS; Laurindo, FR; Lima, RG; Lunardi, CN; Rodrigues, GJ; Santos, CX | 1 |
2 review(s) available for ruthenium and Disease Models, Animal
| Article | Year |
|---|---|
Biological activity of ruthenium nitrosyl complexes.
Topics: Amines; Animals; Antineoplastic Agents; Antiprotozoal Agents; Blood Pressure; Chagas Disease; Disease Models, Animal; Hippocampus; Humans; Leishmaniasis, Cutaneous; Mice; Nitric Oxide; Organometallic Compounds; Photochemistry; Ruthenium; Vasoconstrictor Agents; Vasodilator Agents | 2012 |
Metal complexes as therapeutic agents in nitrogen monoxide modulation.
Topics: Animals; Disease Models, Animal; Humans; Metals; Nitric Oxide; Nitric Oxide Donors; Organometallic Compounds; Ruthenium; Ruthenium Compounds | 2004 |
19 other study(ies) available for ruthenium and Disease Models, Animal
| Article | Year |
|---|---|
Amelioration of risk factors associated with diabetic nephropathy in diet-induced pre-diabetic rats by an uracil-derived diimine ruthenium(II) compound.
Topics: Albuminuria; Aldosterone; Animals; Biomarkers; Cell Adhesion Molecules; Creatinine; Diabetic Nephropathies; Diet, High-Fat; Dietary Carbohydrates; Disease Models, Animal; Hypoglycemic Agents; Intracellular Signaling Peptides and Proteins; Kidney; Male; Membrane Proteins; Organometallic Compounds; Oxidative Stress; Prediabetic State; Rats, Sprague-Dawley; Risk Factors; Ruthenium; Uracil; Urea | 2020 |
Ruthenium complexes as prospective inhibitors of metallo-β-lactamases to reverse carbapenem resistance.
Topics: Amino Acid Sequence; Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Binding Sites; Carbapenems; Coordination Complexes; Disease Models, Animal; Drug Development; Drug Resistance, Microbial; Escherichia coli; Infections; Meropenem; Mice; Microbial Sensitivity Tests; Prospective Studies; Protein Binding; Protein Conformation; Ruthenium; Structure-Activity Relationship; Zinc | 2020 |
Crystalline ruthenium polypyridine nanoparticles: a targeted treatment of bacterial infection with multifunctional antibacterial, adhesion and surface-anchoring photosensitizer properties.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; Bacterial Adhesion; Coordination Complexes; Disease Models, Animal; Escherichia coli; Hemolysis; Indoles; Isoindoles; Mice; Nanoparticles; Photosensitizing Agents; Pyridines; Reactive Oxygen Species; Ruthenium; Surface Properties; Wound Healing | 2021 |
Two-photon dual imaging platform for in vivo monitoring cellular oxidative stress in liver injury.
Topics: Acetaminophen; Animals; Cell Line; Chemical and Drug Induced Liver Injury; Coordination Complexes; Disease Models, Animal; Fluorescent Dyes; Glutathione; Hydrogen Peroxide; Hypochlorous Acid; Liver; Male; Mice; Mice, Inbred BALB C; Microscopy, Fluorescence, Multiphoton; Oxidative Stress; Reactive Oxygen Species; Ruthenium | 2017 |
Ruthenium-conjugated chrysin analogues modulate platelet activity, thrombus formation and haemostasis with enhanced efficacy.
Topics: Animals; Biological Availability; Blood Platelets; Disease Models, Animal; Fibrinolytic Agents; Flavonoids; Hemostasis; Humans; Mice; Platelet Activation; Ruthenium; Thrombosis | 2017 |
Polypyridylruthenium(II) complexes exert in vitro and in vivo nematocidal activity and show significant inhibition of parasite acetylcholinesterases.
Topics: Acetylcholinesterase; Administration, Oral; Animals; Antinematodal Agents; Cholinesterase Inhibitors; Disease Models, Animal; Larva; Male; Mice; Parasite Egg Count; Ruthenium; Trichuriasis; Trichuris | 2018 |
Polypyridylruthenium(II) complexes exert anti-schistosome activity and inhibit parasite acetylcholinesterases.
Topics: Acetylcholinesterase; Animals; Biological Transport; Cholinesterase Inhibitors; Disease Models, Animal; Female; Glucose; Larva; Male; Mice; Organometallic Compounds; Praziquantel; Ruthenium; Schistosoma haematobium; Schistosoma mansoni; Schistosomiasis haematobia; Schistosomiasis mansoni | 2017 |
Rux largely restores lungs in Iraq PM-exposed mice, Up-regulating regulatory T-cells (Tregs).
Topics: Afghan Campaign 2001-; Animals; Disease Models, Animal; Interleukin-15; Iraq; Lung Injury; Mice; Particulate Matter; Ruthenium; T-Lymphocytes, Regulatory; Thioctic Acid; Up-Regulation | 2018 |
Novel ruthenium - gamma-linolenic acid complex inhibits C6 rat glioma cell proliferation in vitro and in the orthotopic C6 model in vivo after osmotic pump infusion.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Extracellular Matrix; Female; gamma-Linolenic Acid; Glioma; Rats; Ruthenium; Tumor Burden | 2014 |
Relaxing effect of a new ruthenium complex nitric oxide donor on airway smooth muscle of an experimental model of asthma in rats.
Topics: Animals; Asthma; Calcium; Disease Models, Animal; Extracellular Space; Guanylate Cyclase; Male; Muscle Relaxation; Muscle, Smooth; Nitric Oxide Donors; Nitroprusside; Organometallic Compounds; Phosphodiesterase Inhibitors; Potassium Channels; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Ruthenium; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Soluble Guanylyl Cyclase; Trachea | 2016 |
Anticancer Activity Studies of Ruthenium(II) Complex Toward Human Osteosarcoma HOS Cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Bone Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Membrane Potential, Mitochondrial; Mice; Molecular Structure; Organometallic Compounds; Osteosarcoma; Reactive Oxygen Species; Ruthenium; Xenograft Model Antitumor Assays | 2016 |
Chloroquine-containing organoruthenium complexes are fast-acting multistage antimalarial agents.
Topics: Animals; Antimalarials; Chloroquine; Disease Models, Animal; Malaria; Mice; Organometallic Compounds; Oxidative Stress; Parasitemia; Plasmodium berghei; Plasmodium falciparum; Ruthenium; Treatment Outcome | 2016 |
Long Blood Residence and Large Tumor Uptake of Ruthenium Sulfide Nanoclusters for Highly Efficient Cancer Photothermal Therapy.
Topics: Animals; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Humans; Hyperthermia, Induced; Metal Nanoparticles; Mice; Neoplasms; Phototherapy; Polyethylene Glycols; Ruthenium; Tissue Distribution; Xenograft Model Antitumor Assays | 2017 |
Involvement of TRPV4-NO-cGMP-PKG pathways in the development of thermal hyperalgesia following chronic compression of the dorsal root ganglion in rats.
Topics: Animals; Behavior, Animal; Cyclic GMP; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Ganglia, Spinal; Hyperalgesia; Male; Nitric Oxide; Nitrites; Oligodeoxyribonucleotides, Antisense; Pain Threshold; Protein Kinase C; Radiculopathy; Rats; Rats, Wistar; Ruthenium; Signal Transduction; Statistics, Nonparametric; TRPV Cation Channels | 2010 |
The CO-releasing molecule CORM-3 protects against articular degradation in the K/BxN serum transfer arthritis model.
Topics: Animals; Arthritis, Experimental; Carbon Monoxide; Cartilage, Articular; Disease Models, Animal; Male; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; Mice, Transgenic; Organometallic Compounds; Ruthenium; Serum | 2010 |
Carbon monoxide-releasing molecule-2 (CORM-2) attenuates acute hepatic ischemia reperfusion injury in rats.
Topics: Acute Disease; Animals; Apoptosis; Blotting, Western; Cytokines; Disease Models, Animal; DNA; In Situ Nick-End Labeling; Ischemia; Liver; Male; NF-kappa B; Organometallic Compounds; Rats; Rats, Wistar; Reperfusion Injury; Ruthenium; Treatment Outcome | 2010 |
Effects of Rut-bpy (Cis-[Ru(bpy)2(SO3)(NO)]PF 6), a novel nitric oxide donor, in L-NAME-induced hypertension in rats.
Topics: Anesthesia; Animals; Blood Pressure; Coordination Complexes; Disease Models, Animal; Hypertension; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Organometallic Compounds; Random Allocation; Rats; Rats, Wistar; Ruthenium; Treatment Outcome; Vasodilator Agents | 2011 |
Primary tumor, lung and kidney retention and antimetastasis effect of NAMI-A following different routes of administration.
Topics: Administration, Inhalation; Administration, Oral; Aerosols; Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Dimethyl Sulfoxide; Disease Models, Animal; Female; Injections, Intraperitoneal; Kidney; Liver; Lung; Lung Neoplasms; Mammary Neoplasms, Animal; Mice; Mice, Inbred Strains; Neoplasm Metastasis; Organometallic Compounds; Ruthenium; Ruthenium Compounds; Species Specificity | 2003 |
Vitamin C improves the effect of a new nitric oxide donor on the vascular smooth muscle from renal hypertensive rats.
Topics: Animals; Aorta; Ascorbic Acid; Calcium; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Hypertension, Renal; Kidney; Male; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Donors; Organ Culture Techniques; Organometallic Compounds; Phenylephrine; Rats; Rats, Wistar; Ruthenium; Superoxides; Time Factors; Vasodilation | 2008 |